Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
American Journal of Hematology|September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findingsPaul J Hampel, Kari G Chaffee, Rebecca L King, et al.Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies <i>MMP16</i> and <i>KCTD15</i> as risk lociJoseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.Haematologica|November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphomaMatthew J Maurer, Carla Casulo, Melissa C Larson, et al.Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.Leukemia|March 7, 2020
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCLKeenan T Hartert, Kerstin Wenzl, Jordan E Krull, et al.Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.Blood Advances|November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO ConsortiumJonathan R Day, Melissa C Larson, Urshila Durani, et al.Blood Cancer Journal|January 9, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapyHervé Ghesquières, Youenn Drouet, Susan L Slager, et al.Cancers|December 10, 2021
CHFR and Paclitaxel Sensitivity of Ovarian CancerAndrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, et al.Hematological Oncology|May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomasMelissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.Pageof 11